Q3694903 (Q3694903): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): The healthcare and health system will face significant financial constraints, in particular due to the increasing number of cancers and inflammatory diseases, which requires the development of innovative low-cost treatments., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
The healthcare and health system will face significant financial constraints, in particular due to the increasing number of cancers and inflammatory diseases, which requires the development of innovative low-cost treatments. (English) | |||||||||||||||
| Property / summary: The healthcare and health system will face significant financial constraints, in particular due to the increasing number of cancers and inflammatory diseases, which requires the development of innovative low-cost treatments. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The healthcare and health system will face significant financial constraints, in particular due to the increasing number of cancers and inflammatory diseases, which requires the development of innovative low-cost treatments. (English) / qualifier | |||||||||||||||
point in time: 22 November 2021
| |||||||||||||||
Revision as of 10:27, 22 November 2021
Project Q3694903 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3694903 in France |
Statements
108,482.0 Euro
0 references
264,338.25 Euro
0 references
41.04 percent
0 references
30 March 2015
0 references
30 September 2017
0 references
Université de Bourgogne
0 references
Le système de soins et de santé va être confronté à d'importantes contraintes financières, notamment en raison du nombre croissant de cancers et de maladies inflammatoires, ce qui nécessite de développer des traitements innovants à faible coût. (French)
0 references
The healthcare and health system will face significant financial constraints, in particular due to the increasing number of cancers and inflammatory diseases, which requires the development of innovative low-cost treatments. (English)
22 November 2021
0 references
Identifiers
BG0003225
0 references